References
- Humm J.L. Dosimetric aspects of radiolabelled antibodies for tumour therapy. Journal of Nuclear Medicine 1986; 27: 490–497
- Moss H.A., Nannis E.D., Poplack D.G. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukaemia. American Journal of Medicine 1981; 71: 47–52
- Richardson R.B., Kemshead J.T., Davies A.G. Dosimetry of intrathecal 131I labelled monoclonal antibody in cases of neoplastic meningitis. European Journal of Nuclear Medicine 1990; 17: 42–48
- Shalet S.M., Beardwell C.G. Hypothalamicpituitary function following cranial irradiation. Radiation Damage to the Nervous System, H.A. Gilbert, A.R. Kagan(s). Raven Press, New York 1980; 202–217, In
- Wheldon T.E., O'Donoghue J.A. The radiobiology of targeted radiotherapy. International Journal of Radiation Biology 1990; 58: 1–21